| Avagacestat |
ENSG00000005206.12 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000088970.11 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000088970.11 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000118412.8 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000149656.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000157306.10 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000160336.10 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000167912.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000170161.6 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000170590.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000170590.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000171889.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000172250.10 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000175701.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000177406.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000177406.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000177406.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000177757.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000177993.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000178412.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000178412.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000178977.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000179743.2 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000179818.9 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000179935.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000180139.10 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000180458.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000180846.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000181798.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000182057.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000182165.13 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000182366.5 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000185186.4 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000185495.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000185495.6 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000185837.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000185837.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000186369.5 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000186594.8 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000187229.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000187979.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000188206.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000188206.5 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000188365.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000188424.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000188660.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000188693.7 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000188825.9 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000189223.9 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000196559.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000196668.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000196696.8 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000196810.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000197308.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000197332.7 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000197934.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000203321.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000203325.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000203325.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000203327.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000203356.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000203496.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000203520.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000203706.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000203706.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000203706.4 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000203709.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000203999.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000204054.7 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000204241.3 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000204685.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000204802.3 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000204837.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000204929.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000204934.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000205037.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000205041.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000205266.5 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000205500.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000205662.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000205663.5 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000211683.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000211683.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000212978.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000214146.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000214407.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000214407.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Avagacestat |
ENSG00000214719.7 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000214770.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000214773.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000214773.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000214773.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000214837.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000215022.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000215159.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000215190.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000215374.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000215386.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000215417.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000215424.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000215458.4 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000215498.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000215533.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000215692.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000215863.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000215863.2 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000215908.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000217258.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000217576.7 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000218018.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000219665.4 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000222035.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000222041.6 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000223356.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000223374.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000223380.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000223478.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000223522.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000223528.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000223561.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000223571.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Avagacestat |
ENSG00000223576.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000223579.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000223685.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000223692.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000223697.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000223725.2 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000223734.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000223734.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000223759.2 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000223784.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000223799.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000223799.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000223804.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000223804.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000223809.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000223811.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000223813.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000223813.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000223829.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000223882.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000223901.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000223923.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000223935.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000223956.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000223960.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000223975.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000224000.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000224020.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000224046.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000224046.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000224078.8 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000224100.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000224174.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000224189.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000224269.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Avagacestat |
ENSG00000224281.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000224292.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000224376.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000224376.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000224441.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000224505.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000224533.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000224577.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000224592.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000224609.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000224621.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000224621.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000224660.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000224671.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000224707.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000224844.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000224855.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000224863.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000224888.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000224888.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000224905.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000224914.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000224945.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000224961.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000224969.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000224975.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000224975.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000224977.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000224985.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000224995.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000225063.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000225076.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000225092.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000225096.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000225111.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000225113.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000225138.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000225138.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000225146.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000225187.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000225194.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000225218.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000225234.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000225278.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000225300.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000225335.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000225353.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000225377.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000225434.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000225434.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000225489.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000225498.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000225511.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000225602.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000225611.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000225675.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000225703.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000225703.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000225721.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000225725.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000225744.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000225744.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000225751.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000225760.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000225764.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000225767.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000225791.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000225798.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000225806.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000225822.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000225850.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000225868.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000225891.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000225956.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000225969.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000225975.2 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000226007.2 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000226051.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000226053.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000226067.2 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000226089.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000226149.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000226245.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000226276.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000226277.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000226310.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000226312.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000226312.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000226334.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000226363.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000226375.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000226380.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000226383.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000226386.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000226416.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000226453.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000226471.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000226471.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000226645.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000226659.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000226690.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000226853.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000226883.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000226904.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000226913.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000226920.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000226944.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000226950.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000226950.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000226950.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000226954.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000226954.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000226965.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000227005.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000227017.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000227028.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000227036.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000227036.2 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000227039.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000227060.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000227083.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000227128.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000227161.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000227186.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000227197.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000227197.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000227200.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000227215.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000227218.3 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000227237.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000227237.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000227252.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000227256.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000227258.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000227258.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000227258.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000227308.2 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000227373.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000227375.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000227388.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000227398.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000227407.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000227409.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000227492.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000227508.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000227518.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000227527.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000227533.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000227627.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000227630.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000227695.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000227698.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000227704.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000227740.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000227741.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000227764.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000227811.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000227908.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000227946.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000227953.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000227959.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000227963.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000228028.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000228028.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000228044.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000228061.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000228063.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000228063.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000228065.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000228072.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000228084.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000228084.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000228109.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000228124.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000228126.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000228137.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000228141.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000228176.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000228204.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000228223.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000228237.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000228242.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000228288.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000228302.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000228302.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000228313.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000228315.7 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000228323.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000228327.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000228352.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000228353.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000228363.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000228369.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000228382.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000228386.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000228389.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000228389.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000228393.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000228393.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000228404.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000228423.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000228452.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000228470.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000228544.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000228614.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000228643.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000228649.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000228649.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000228686.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000228701.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000228719.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000228737.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000228779.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000228786.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000228791.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000228791.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000228798.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000228802.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000228809.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000228817.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000228838.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000228838.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000228839.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000228886.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000228917.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000229005.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000229017.2 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000229021.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000229021.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000229105.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000229111.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000229122.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000229124.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000229137.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000229153.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000229153.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000229180.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000229180.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000229291.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000229321.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000229368.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000229512.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000229539.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000229539.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000229587.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000229587.2 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000229589.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000229589.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000229647.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000229647.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000229656.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000229660.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000229666.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000229672.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000229672.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000229694.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000229728.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000229728.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000229832.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000229841.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000229848.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000229852.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000229862.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000229869.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000229874.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000229951.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000229951.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000229956.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000229986.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000230005.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000230065.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000230082.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000230155.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000230155.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000230177.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000230285.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000230289.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000230289.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000230310.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000230366.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000230368.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Avagacestat |
ENSG00000230415.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Avagacestat |
ENSG00000230417.6 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000230479.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000230479.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000230530.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000230555.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000230561.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000230606.6 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000230613.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000230699.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000230724.5 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000230736.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000230815.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000230817.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000230825.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000230826.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000230914.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000230925.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000230990.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000231054.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000231064.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000231073.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000231081.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000231092.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000231125.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000231134.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000231154.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000231156.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000231185.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000231193.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000231255.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Avagacestat |
ENSG00000231272.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000231298.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000231367.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000231393.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000231401.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000231407.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000231424.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000231428.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000231527.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000231530.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000231560.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000231563.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000231574.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000231595.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000231595.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000231609.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000231611.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000231646.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000231704.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000231724.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000231724.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000231734.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000231742.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000231742.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000231817.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000231829.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000231842.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000231842.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000231865.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000231920.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000231993.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000232023.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000232053.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000232082.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000232098.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000232116.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000232118.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000232192.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000232224.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Avagacestat |
ENSG00000232224.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000232233.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000232284.3 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000232295.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000232295.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000232298.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000232310.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000232342.3 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000232377.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000232388.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000232401.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000232412.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000232415.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000232458.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000232487.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000232490.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000232519.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000232530.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000232545.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000232564.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000232564.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000232586.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000232613.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000232623.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000232633.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000232645.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000232650.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000232656.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000232686.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000232686.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000232693.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000232694.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000232712.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000232712.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000232762.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000232807.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000232811.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000232811.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000232814.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000232814.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000232860.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000232876.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000232909.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000232931.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000232931.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000232940.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000232940.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000232973.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000232973.7 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000232986.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000233077.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000233081.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000233143.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000233154.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000233191.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000233220.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000233220.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000233221.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000233237.2 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000233368.2 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000233384.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000233393.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000233396.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000233429.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000233483.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000233509.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000233509.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000233509.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000233527.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000233532.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000233602.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000233602.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000233613.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000233621.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000233642.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000233651.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000233654.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000233725.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000233785.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000233797.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000233799.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000233818.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000233818.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000233845.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000233901.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000233922.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000233942.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000233967.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000234006.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000234019.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000234160.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000234160.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000234174.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000234185.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000234197.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000234230.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000234232.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000234350.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000234380.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000234380.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000234396.3 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000234428.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000234478.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000234509.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000234509.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000234535.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000234584.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000234608.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000234614.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000234617.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000234617.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000234630.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000234630.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000234650.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000234665.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Avagacestat |
ENSG00000234665.4 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000234684.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000234684.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000234694.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000234698.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000234703.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000234705.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000234722.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000234740.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000234753.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000234772.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000234779.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000234789.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000234817.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000234899.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000234900.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000234902.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000234913.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000234917.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000234917.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000234936.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000234943.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000234978.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000235029.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000235049.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000235072.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000235079.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000235079.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000235091.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000235096.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000235138.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000235138.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000235138.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000235159.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000235236.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000235245.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000235245.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000235298.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000235314.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000235319.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000235373.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000235381.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000235398.4 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000235419.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000235423.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000235427.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000235427.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000235445.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000235448.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000235475.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000235481.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000235499.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000235499.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000235501.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000235501.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000235527.2 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000235530.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000235560.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000235609.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000235629.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000235641.3 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000235652.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000235663.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000235726.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000235806.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000235843.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000235881.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000235884.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000235884.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000235897.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000235903.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000235908.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000235910.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000235919.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000235934.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000235958.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000235999.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000236013.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000236051.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000236081.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000236140.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000236194.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000236199.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000236206.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000236234.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000236299.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000236308.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000236337.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000236388.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000236390.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000236423.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000236434.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000236438.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000236467.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000236498.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000236510.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000236514.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000236514.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Avagacestat |
ENSG00000236519.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000236519.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000236520.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000236601.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000236671.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000236673.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000236708.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000236753.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000236753.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000236772.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000236772.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000236861.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000236861.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000236869.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000236886.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000236896.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000236914.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000236933.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000236935.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000236943.2 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000236977.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000237015.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000237017.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000237073.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000237094.7 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000237126.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000237126.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000237149.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000237153.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000237167.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000237184.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000237187.4 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000237187.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000237187.4 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000237188.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000237200.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000237222.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000237234.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000237248.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000237298.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000237310.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000237343.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000237343.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000237352.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000237356.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000237424.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000237438.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000237481.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000237489.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000237491.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000237502.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000237529.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000237605.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000237613.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000237686.2 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000237689.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000237718.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000237718.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000237742.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000237772.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000237803.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000237857.2 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000237862.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Avagacestat |
ENSG00000237877.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000237886.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000237993.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000238035.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000238039.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000238043.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000238045.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000238045.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000238045.5 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000238142.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000238178.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000238186.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000238217.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000238224.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000238279.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000238280.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000238287.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000239300.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000239335.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000239377.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000239377.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000239508.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000239519.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000239569.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000239569.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000239608.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000239828.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000239906.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000240006.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000240050.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000240057.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000240137.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000240137.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000240143.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000240207.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000240291.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000240440.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000240440.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000240449.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000240498.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000240541.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000240541.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000240571.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000240571.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000240618.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000240859.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000240922.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Avagacestat |
ENSG00000241014.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000241180.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000241219.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000241280.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000241280.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Avagacestat |
ENSG00000241288.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000241316.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000241317.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000241481.2 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000241544.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000241544.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000241570.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000241679.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Avagacestat |
ENSG00000241679.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000241732.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000241769.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000241818.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000241860.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000241954.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000242082.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000242154.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000242242.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000242282.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000242288.6 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000242396.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000242474.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000242553.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000242791.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000242861.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000243055.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000243107.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000243243.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000243433.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000243485.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000243637.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000243960.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000244055.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000244137.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000244198.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000244268.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000244268.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000244327.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000244332.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000244380.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000244393.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000244479.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000244479.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000244625.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000244649.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000244675.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000244791.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000244879.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000245060.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000245060.2 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000245146.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000245149.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000245213.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000245311.2 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000245498.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000245498.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000245526.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000245571.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000245571.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000245685.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000245729.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Avagacestat |
ENSG00000245768.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000245849.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000246130.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000246130.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000246228.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000246331.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000246731.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000246763.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000246859.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000246863.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000246863.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000246863.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000246877.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000246898.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000247081.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000247151.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000247199.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000247199.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000247228.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000247373.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000247416.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000247572.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000247765.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000247853.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000247853.2 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000247877.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000247925.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Avagacestat |
ENSG00000247950.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000247950.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000247982.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000248019.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000248115.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000248240.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000248240.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000248243.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000248265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000248367.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000248367.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000248399.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000248445.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000248476.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000248476.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000248479.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000248514.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000248538.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000248559.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000248596.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000248607.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000248629.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000248664.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000248677.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000248724.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000248758.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000248866.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000248866.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000248925.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000248925.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000248927.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000248932.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000248936.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000249084.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000249094.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000249096.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000249196.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000249304.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000249304.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000249309.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000249328.2 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000249348.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000249426.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000249464.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000249476.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000249476.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000249483.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000249550.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000249572.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000249595.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000249637.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000249650.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000249655.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000249655.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000249685.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000249806.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000249825.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000249867.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000249898.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000249996.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000250012.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000250033.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000250057.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000250069.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000250073.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000250075.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000250107.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000250116.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000250131.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000250133.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000250240.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000250286.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000250295.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000250326.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000250402.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000250432.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000250551.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000250582.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000250659.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000250708.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000250740.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000250748.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000250770.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000250786.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000250786.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000250846.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000250891.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000250893.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000250893.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000250899.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000250900.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000250900.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000250900.2 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000250909.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000250938.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000250938.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000250950.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000250958.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000250988.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000250988.3 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000250990.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000250999.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000251018.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000251031.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000251054.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000251075.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000251161.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000251161.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000251173.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000251179.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000251257.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000251279.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000251309.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000251314.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000251323.2 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000251361.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000251396.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000251405.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000251460.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000251497.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000251523.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000251532.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000251611.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000251661.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000251666.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000251867.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000253106.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000253133.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000253167.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000253174.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000253301.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000253327.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000253390.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000253399.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000253414.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000253476.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000253519.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000253526.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000253539.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000253559.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000253636.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000253641.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000253669.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000253671.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000253695.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000253733.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000253738.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000253744.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000253754.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000253807.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000253837.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000253848.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000253854.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000253854.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000253864.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000253893.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000253898.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000253917.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000253921.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000253948.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000253965.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000253978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000253982.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000254003.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000254027.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000254028.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000254031.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000254034.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000254094.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000254099.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000254099.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000254142.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000254142.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000254162.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000254165.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000254207.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000254208.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000254226.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000254226.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000254248.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000254267.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000254275.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000254275.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000254281.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000254340.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000254341.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000254341.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000254362.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000254370.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000254389.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Avagacestat |
ENSG00000254401.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000254427.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000254428.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000254431.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000254444.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000254459.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000254460.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000254461.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000254461.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000254477.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000254495.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000254526.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000254528.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000254551.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000254615.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000254635.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000254648.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000254682.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000254689.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000254694.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000254699.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000254718.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000254718.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000254756.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000254756.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000254756.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000254762.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000254821.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000254833.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000254847.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000254854.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000254855.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Avagacestat |
ENSG00000254859.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000254862.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000254869.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000254872.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000254907.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000254929.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000254985.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000255029.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000255029.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000255045.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000255050.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000255079.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000255089.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000255090.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000255100.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000255100.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000255135.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000255139.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000255142.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000255145.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000255153.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000255158.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000255158.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000255164.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000255165.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000255176.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000255186.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000255227.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000255234.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000255236.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000255310.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000255313.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000255314.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000255343.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000255345.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000255354.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000255409.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000255421.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000255421.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000255440.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000255446.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000255449.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000255449.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000255458.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000255476.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000255495.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000255507.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000255521.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000255559.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000255559.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000255568.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000255571.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000255651.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000255651.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000255652.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000255670.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000255723.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000255790.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000255871.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000255933.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000255946.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000255989.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000255989.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000255992.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000256001.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000256025.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000256101.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000256116.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000256196.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000256278.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000256448.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000256482.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000256482.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000256538.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000256546.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000256576.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000256588.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000256705.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000256705.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000256712.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000256751.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000256802.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000256824.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000256824.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000256940.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000256940.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000257052.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000257052.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000257086.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000257126.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000257135.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000257135.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Avagacestat |
ENSG00000257137.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000257137.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000257151.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000257202.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000257222.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000257252.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000257256.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000257256.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000257270.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000257322.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000257354.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000257366.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000257381.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000257391.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000257391.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000257449.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000257474.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000257488.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000257496.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000257496.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000257507.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000257557.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000257563.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000257563.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000257657.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000257740.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000257754.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000257759.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000257808.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000257808.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000257815.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000257815.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000257953.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000257999.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000258035.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000258048.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000258048.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000258088.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000258096.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000258099.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000258101.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000258136.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000258260.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000258301.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000258302.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000258317.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000258343.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000258413.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000258414.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000258428.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000258441.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000258454.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000258455.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000258458.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000258458.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000258486.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000258486.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000258515.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000258517.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000258520.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000258525.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000258526.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000258545.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000258548.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000258558.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000258561.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000258593.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000258602.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000258603.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000258612.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000258623.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000258646.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000258658.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000258658.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000258704.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000258731.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000258813.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000258821.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000258825.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000258851.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000258857.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000258884.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000258904.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000258920.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000258922.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000258935.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000258935.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000258940.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000258940.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000258983.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000258983.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000258999.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000259002.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000259039.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000259048.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000259093.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000259103.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000259116.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000259116.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000259135.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000259138.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000259138.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000259178.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000259209.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000259212.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000259215.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000259218.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000259240.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000259244.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000259248.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000259251.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000259264.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000259276.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000259287.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000259310.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000259322.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000259327.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000259336.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000259341.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000259345.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000259349.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000259364.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000259366.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000259372.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000259372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000259408.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000259410.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000259416.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000259424.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000259426.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000259447.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000259488.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000259521.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000259542.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000259561.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000259563.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000259563.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000259577.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000259595.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000259617.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000259617.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000259623.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000259635.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000259640.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000259644.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000259654.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000259673.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000259678.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000259687.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000259709.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000259709.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000259713.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000259736.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000259755.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000259756.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000259758.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000259768.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000259771.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000259772.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000259783.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000259792.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000259793.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000259797.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000259799.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000259806.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000259820.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000259826.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000259840.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000259867.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000259877.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000259891.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000259894.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000259915.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000259921.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000259933.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000259967.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000259972.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000259972.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000260005.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000260008.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000260017.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000260037.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000260038.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000260046.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000260051.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000260063.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000260093.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000260132.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000260132.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000260132.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000260136.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000260176.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000260177.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000260190.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000260209.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000260231.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000260231.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000260233.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000260252.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000260261.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000260277.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000260279.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000260285.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000260288.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000260296.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000260306.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000260306.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000260316.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000260316.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000260317.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000260331.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000260336.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000260361.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000260364.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000260367.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000260377.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000260377.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000260394.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000260396.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000260400.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000260400.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000260409.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000260409.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000260423.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000260441.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000260448.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000260454.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000260475.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000260526.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000260534.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000260563.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000260572.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000260586.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000260588.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000260591.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000260604.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000260608.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000260619.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000260626.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000260635.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000260637.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000260643.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000260645.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000260645.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000260648.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000260651.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000260661.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000260671.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000260672.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000260693.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000260698.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000260711.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000260735.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000260735.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000260744.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000260766.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000260773.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000260790.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000260803.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000260823.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000260834.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000260837.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000260840.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000260841.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000260877.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000260880.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000260884.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000260884.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000260891.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000260891.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000260895.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000260905.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000260912.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000260927.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000260927.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000260931.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000260936.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000260949.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000260953.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000260954.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000260977.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000260977.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000260978.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000260992.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000260992.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000261000.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000261003.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000261033.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Avagacestat |
ENSG00000261033.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000261039.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000261043.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000261069.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000261080.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000261083.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000261098.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000261101.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000261105.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000261114.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000261123.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000261124.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000261135.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000261167.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000261173.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000261186.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000261186.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000261187.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000261188.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000261195.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000261200.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000261216.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000261226.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000261251.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000261251.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000261254.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000261267.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000261286.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000261288.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000261305.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000261314.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000261334.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000261337.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000261360.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000261360.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000261372.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000261396.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000261396.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000261404.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000261430.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000261433.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000261437.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000261438.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000261442.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000261468.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000261471.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000261474.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000261478.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000261488.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000261490.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000261526.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000261542.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000261574.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000261592.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000261592.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000261595.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000261610.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000261610.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000261632.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000261634.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000261634.2 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000261654.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000261663.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000261669.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000261669.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000261690.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000261695.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000261707.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000261744.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000261758.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000261758.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000261775.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000261799.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000261801.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000261838.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000261888.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000261916.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000261924.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000261925.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000261971.2 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000261996.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000262001.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000262089.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000262115.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000262136.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000262147.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000262152.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000262155.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Avagacestat |
ENSG00000262165.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000262171.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000262194.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000262202.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000262202.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000262228.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000262294.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000262319.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000262362.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000262372.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000262434.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000262454.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000262585.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000262652.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000262663.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000262681.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000262686.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000262837.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000262905.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000262952.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000262979.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000262979.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000263063.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000263063.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000263069.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000263182.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000263182.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000263214.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000263214.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000263272.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000263307.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000263325.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000263327.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000263388.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000263393.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000263412.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000263612.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000263624.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000263680.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000263718.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000263718.2 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000263753.2 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000263766.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000263843.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000263847.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000263860.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000263874.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000263924.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000263982.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000264012.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000264125.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000264188.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000264235.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000264247.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000264270.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000264304.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000264304.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000264365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000264456.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000264486.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000264575.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000264595.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000264608.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000264635.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000264666.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000264672.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000264859.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000264885.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000264937.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000265010.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000265091.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000265242.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000265342.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000265349.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000265394.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000265394.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000265399.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000265443.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000265474.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000265478.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000265490.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000265511.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000265511.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000265519.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000265542.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000265625.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000265688.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000265750.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000265750.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000265791.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000265845.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000265845.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000265912.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000265933.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000265971.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000266010.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000266053.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000266176.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000266236.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000266289.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000266289.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000266311.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000266340.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000266340.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000266340.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000266521.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000266651.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000266709.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000266709.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000266717.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000266744.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000266783.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000266805.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000266824.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000266844.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000266850.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000266877.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000266896.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000266900.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000266903.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000266912.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000266916.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000266918.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000266926.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000266947.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000266983.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000267002.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000267010.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000267016.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000267025.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000267025.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000267044.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000267058.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000267064.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000267080.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000267082.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000267108.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000267117.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000267138.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000267150.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000267159.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000267167.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000267167.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000267167.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000267175.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000267197.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000267197.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000267213.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000267222.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000267230.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000267232.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000267243.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000267244.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000267249.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000267249.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000267263.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000267274.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000267279.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000267304.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000267325.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000267344.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000267347.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000267347.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000267348.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000267374.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000267374.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000267405.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000267414.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000267419.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000267432.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000267439.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000267439.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000267446.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000267470.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000267476.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000267480.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000267481.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000267501.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000267547.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000267551.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000267551.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000267560.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000267563.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000267565.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000267568.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000267582.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000267583.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000267586.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000267658.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000267666.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000267667.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000267672.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000267682.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000267709.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000267711.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000267711.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000267715.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000267751.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000267761.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000267778.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000267786.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000267804.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000267834.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000267838.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000267838.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000267852.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000267871.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000267927.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000267927.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000267940.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000268001.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000268001.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000268049.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000268049.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000268061.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000268093.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000268204.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000268204.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000268230.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000268262.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000268289.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000268307.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000268362.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000268362.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000268366.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000268471.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000268518.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000268530.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000268530.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000268584.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000268601.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000268605.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000268650.3 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000268670.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000268683.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000268707.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000268764.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000268894.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000268945.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000269054.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000269161.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000269161.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000269172.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000269202.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000269202.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000269235.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000269352.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000269397.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000269423.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000269425.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000269444.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000269481.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000269483.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000269487.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000269534.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000269535.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000269609.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000269653.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000269680.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000269814.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000269815.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000269815.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000269834.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000269893.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000269896.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000269901.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000269903.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000269910.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000269940.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000269951.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000269951.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000269951.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000269958.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000269959.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000269961.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000269966.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000269973.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000269973.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000269979.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000269980.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000269983.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000269983.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000269996.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000269999.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000270001.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000270015.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000270015.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000270031.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000270036.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000270048.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000270048.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000270055.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000270055.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000270060.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000270062.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000270068.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000270074.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000270095.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000270097.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000270116.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000270130.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000270141.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000270154.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000270164.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000270168.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000270168.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000270177.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000270184.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000270190.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000270210.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000270237.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000270246.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000270346.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000270346.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000270419.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000270419.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000270426.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000270557.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000270562.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000270571.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000270580.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000270599.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000270640.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000270640.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000270704.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000270720.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000270760.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000270820.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000270876.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000270951.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000270964.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000271009.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000271185.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000271185.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000271199.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000271204.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000271218.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000271228.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000271327.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000271327.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000271344.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000271533.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000271551.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000271551.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000271553.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000271659.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000271659.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000271659.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000271737.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000271752.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000271755.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000271757.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000271778.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000271778.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000271778.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000271782.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000271788.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000271789.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000271815.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000271816.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000271825.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000271825.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000271826.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000271835.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000271840.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000271843.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000271843.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000271869.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000271874.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000271874.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000271888.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000271916.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000271921.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000271921.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000271931.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000271943.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000271963.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Avagacestat |
ENSG00000271963.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000271967.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Avagacestat |
ENSG00000271971.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000271971.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000271991.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000271993.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000272029.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000272040.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000272048.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000272065.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000272072.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000272076.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000272077.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000272079.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000272121.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000272129.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000272141.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000272143.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000272148.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000272156.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000272161.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000272172.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000272181.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000272183.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000272191.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000272205.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000272209.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000272216.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000272217.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Avagacestat |
ENSG00000272221.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000272225.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000272225.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000272248.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000272248.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000272250.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000272254.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000272263.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000272263.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000272273.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000272275.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000272282.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000272316.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000272320.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000272320.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000272330.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000272338.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000272373.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000272377.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000272377.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000272389.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000272389.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000272402.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000272403.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000272417.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000272420.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000272425.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000272438.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000272444.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000272444.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000272447.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000272459.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000272462.2 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000272463.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000272479.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000272482.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000272516.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000272519.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000272520.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000272523.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000272524.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000272525.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000272529.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000272562.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000272583.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000272604.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000272610.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000272627.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000272630.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000272631.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000272631.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000272650.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000272657.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000272688.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000272689.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000272690.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Avagacestat |
ENSG00000272692.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000272695.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000272699.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000272707.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000272717.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000272735.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000272754.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000272760.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000272761.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000272764.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000272769.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000272780.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000272782.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000272782.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000272795.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000272795.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000272800.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000272810.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000272812.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000272829.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000272836.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000272836.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000272858.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000272892.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000272895.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000272905.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000272931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000272953.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000272970.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000272977.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000272983.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000272984.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000273000.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000273007.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000273007.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000273009.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000273017.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000273017.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Avagacestat |
ENSG00000273017.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000273035.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000273038.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000273058.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000273081.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000273091.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000273102.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000273104.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000273107.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000273116.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000273116.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000273117.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000273125.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000273139.1 |
Predicted lncRNA |
Kidney renal clear cell carcinoma |
|
| Avagacestat |
ENSG00000273143.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000273145.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000273162.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000273162.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000273164.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000273175.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000273183.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000273203.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000273216.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000273216.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000273218.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000273248.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000273249.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000273253.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000273264.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Avagacestat |
ENSG00000273264.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000273264.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000273265.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000273270.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000273306.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000273306.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000273307.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000273308.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000273329.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000273341.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000273350.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000273353.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Avagacestat |
ENSG00000273355.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000273355.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000273365.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000273372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Avagacestat |
ENSG00000273373.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000273373.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Avagacestat |
ENSG00000273374.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000273374.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000273381.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000273399.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000273406.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000273424.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Avagacestat |
ENSG00000273424.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Avagacestat |
ENSG00000273437.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Avagacestat |
ENSG00000273443.1 |
Predicted lncRNA |
Sarcoma |
|
| Avagacestat |
ENSG00000273448.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Avagacestat |
ENSG00000273456.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Avagacestat |
ENSG00000273481.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Avagacestat |
ENSG00000273488.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|